HK Stock Market Move | CONSUN PHARMA (01681) surges more than 7% to a new high, included in the Hang Seng Composite Index, institutions believe it is likely to be included in the Connect.

CONSUN PHARMA (01681) rose more than 7%, reaching a new high of HK$19.49. As of the time of writing, it has risen 7.57% to HK$19.46 with a trading volume of HK$31.3377 million. On the news front, on February 13, Hang Seng Index Company announced the quarterly review results of the Hang Seng Index series until December 31, 2025, with CONSUN PHARMA included in the Hang Seng Composite Index. The changes will be implemented after the market closes on March 6, 2026, and will take effect on March 9, 2026. At that time, the Shanghai and Shenzhen Stock Exchanges will adjust the scope of eligible stocks for the Hong Kong Stock Connect. According to a research report by Zhongjin, CONSUN PHARMA may be included in the Hong Kong Stock Connect due to meeting a series of criteria including market value, liquidity, and listing time. It is worth mentioning that the company announced at the end of last month that the board of directors has decided to further implement another share buyback plan based on the repurchase authorization, to repurchase shares in the open market at the appropriate time, in addition to the total funds of the previous share buyback plan, adding up to a maximum of HK$100 million. The total funds planned to be used for this share repurchase plan will not exceed HK$300 million. The board of directors is confident in the company's business development and prospects, believing that the current stock price does not fully reflect its intrinsic value and long-term growth potential.